171 related articles for article (PubMed ID: 9700724)
41. Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models.
Kawai S; Yoshimura Y; Iida S; Kinoshita Y; Koishihara Y; Ozaki S; Matsumoto T; Kosaka M; Yamada-Okabe H
Oncol Rep; 2006 Feb; 15(2):361-7. PubMed ID: 16391855
[TBL] [Abstract][Full Text] [Related]
42. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
[TBL] [Abstract][Full Text] [Related]
43. Binding properties of IgE receptors on normal mouse mast cells.
Sterk AR; Ishizaka T
J Immunol; 1982 Feb; 128(2):838-43. PubMed ID: 7054296
[TBL] [Abstract][Full Text] [Related]
44. Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.
Cassard L; Cohen-Solal JF; Galinha A; Sastre-Garau X; Mathiot C; Galon J; Dorval T; Bernheim A; Fridman WH; Sautès-Fridman C
J Clin Invest; 2002 Nov; 110(10):1549-57. PubMed ID: 12438452
[TBL] [Abstract][Full Text] [Related]
45. Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.
Amoroso AR; Clark JI; Litwin S; Hsieh-Ma S; Shi T; Alpaugh RK; Adams GP; Wolf EJ; Ring DB; Weiner LM
Cancer Res; 1996 Jan; 56(1):113-20. PubMed ID: 8548750
[TBL] [Abstract][Full Text] [Related]
46. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
[TBL] [Abstract][Full Text] [Related]
47. IgE enhances specific antibody and T-cell responses in mice overexpressing CD23.
Carlsson F; Hjelm F; Conrad DH; Heyman B
Scand J Immunol; 2007; 66(2-3):261-70. PubMed ID: 17635803
[TBL] [Abstract][Full Text] [Related]
48. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
49. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
[TBL] [Abstract][Full Text] [Related]
50. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
[TBL] [Abstract][Full Text] [Related]
51. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
52. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
[TBL] [Abstract][Full Text] [Related]
53. Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor: implications for the mechanisms of action.
Lammerts van Bueren JJ; Bleeker WK; Bøgh HO; Houtkamp M; Schuurman J; van de Winkel JG; Parren PW
Cancer Res; 2006 Aug; 66(15):7630-8. PubMed ID: 16885363
[TBL] [Abstract][Full Text] [Related]
54. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody.
Hashimoto Y; Sugawara M; Masuko T; Hojo H
Cancer Res; 1983 Nov; 43(11):5328-34. PubMed ID: 6616468
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
[TBL] [Abstract][Full Text] [Related]
56. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies.
Matsuda H; Ushio H; Geba GP; Askenase PW
J Immunol; 1997 Mar; 158(6):2891-7. PubMed ID: 9058826
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of the IgE Fc receptors on rat macrophages induced by elevated serum IgE levels.
Boltz-Nitulescu G; Plummer JM; Spiegelberg HL
Immunology; 1984 Sep; 53(1):9-16. PubMed ID: 6236146
[TBL] [Abstract][Full Text] [Related]
58. Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.
López AF; Strath M; Sanderson CJ
Immunology; 1983 Mar; 48(3):503-9. PubMed ID: 6219064
[TBL] [Abstract][Full Text] [Related]
59. Biologically active molecules regulating the IgE antibody system: biochemical and biological comparisons of suppressive factor of allergy (SFA) and enhancing factor of allergy (EFA).
Katz DH; Chen SS; Liu FT; Bogowitz CA; Katz LR
J Mol Cell Immunol; 1984; 1(3):157-66. PubMed ID: 6242855
[TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
